What's New on the FDA Drugs Site
September 10, 2015
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Safety Communication: FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density
- FDA Drug Shortages
- Tobramycin Injection (Updated - Currently in Shortage)
- Homeopathic Product Regulation: Evaluating FDA’s Regulatory Framework After a Quarter-Century (updated)
- National Drug Code Directory
.png)
No hay comentarios:
Publicar un comentario